FI20080326A0 - Neurotroofinen tekijä MANF ja sen käytöt - Google Patents
Neurotroofinen tekijä MANF ja sen käytötInfo
- Publication number
- FI20080326A0 FI20080326A0 FI20080326A FI20080326A FI20080326A0 FI 20080326 A0 FI20080326 A0 FI 20080326A0 FI 20080326 A FI20080326 A FI 20080326A FI 20080326 A FI20080326 A FI 20080326A FI 20080326 A0 FI20080326 A0 FI 20080326A0
- Authority
- FI
- Finland
- Prior art keywords
- neurotrophic factor
- manf
- factor manf
- neurotrophic
- factor
- Prior art date
Links
- 101000616876 Homo sapiens Mesencephalic astrocyte-derived neurotrophic factor Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20080326A FI20080326A0 (fi) | 2008-04-30 | 2008-04-30 | Neurotroofinen tekijä MANF ja sen käytöt |
US12/433,345 US8853166B2 (en) | 2008-04-30 | 2009-04-30 | Neurotrophic factor MANF and uses thereof |
DK09738284.0T DK2276778T3 (en) | 2008-04-30 | 2009-04-30 | Neurotrophic factor MANF as well as applications thereof |
ES09738284.0T ES2530222T3 (es) | 2008-04-30 | 2009-04-30 | Factor neurotrófico MANF y usos del mismo |
PCT/FI2009/050346 WO2009133247A1 (fr) | 2008-04-30 | 2009-04-30 | Facteur neurotrophique manf et ses utilisations |
CA2725128A CA2725128C (fr) | 2008-04-30 | 2009-04-30 | Facteur neurotrophique manf et ses utilisations |
EP09738284.0A EP2276778B1 (fr) | 2008-04-30 | 2009-04-30 | Facteur neurotrophique manf et ses utilisations |
US14/480,975 US9592270B2 (en) | 2008-04-30 | 2014-09-09 | Neurotrophic factor MANF and uses thereof |
HRP20150095AT HRP20150095T1 (en) | 2008-04-30 | 2015-01-26 | Neurotrophic factor manf and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20080326A FI20080326A0 (fi) | 2008-04-30 | 2008-04-30 | Neurotroofinen tekijä MANF ja sen käytöt |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20080326A0 true FI20080326A0 (fi) | 2008-04-30 |
Family
ID=39385893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20080326A FI20080326A0 (fi) | 2008-04-30 | 2008-04-30 | Neurotroofinen tekijä MANF ja sen käytöt |
Country Status (8)
Country | Link |
---|---|
US (2) | US8853166B2 (fr) |
EP (1) | EP2276778B1 (fr) |
CA (1) | CA2725128C (fr) |
DK (1) | DK2276778T3 (fr) |
ES (1) | ES2530222T3 (fr) |
FI (1) | FI20080326A0 (fr) |
HR (1) | HRP20150095T1 (fr) |
WO (1) | WO2009133247A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1373502T3 (da) | 2001-03-20 | 2011-01-10 | Amarantus Therapeutics Inc | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf |
BRPI0909221A2 (pt) * | 2008-03-25 | 2015-08-11 | Amarantus Therapeutics Inc | Desordens neurodegenerativas |
WO2010042728A1 (fr) * | 2008-10-08 | 2010-04-15 | Cornell University | Modulateurs à petite molécule d'une absorption de prongf |
EP2684050B1 (fr) * | 2011-03-11 | 2016-05-11 | Roche Diagnostics GmbH | Armet en tant que marqueur pour une maladie pulmonaire obstructive chronique (copd) |
ES2594605T3 (es) * | 2011-06-09 | 2016-12-21 | University Of Miami | Factores neurotróficos MANF y CDNF para uso en el tratamiento de trastornos de la retina |
FI20115870A0 (fi) * | 2011-09-05 | 2011-09-05 | Urmas Arumaee | Neuroprotektiiviset soluihin tunkeutuvat peptidit |
US9891231B2 (en) * | 2012-01-24 | 2018-02-13 | University Of Massachusetts | Soluble MANF in pancreatic β-cell disorders |
WO2014066686A1 (fr) * | 2012-10-24 | 2014-05-01 | Amarantus Bioscience Holdings, Inc. | Cibles cérébrales pour facteurs neurotrophiques en vue de traiter une maladie neurodégénérative |
WO2014191630A2 (fr) * | 2013-05-28 | 2014-12-04 | Helsingin Yliopisto | Modèle animal non humain codant pour un gène manf non fonctionnel |
WO2015061856A1 (fr) | 2013-10-30 | 2015-05-07 | University Of Western Australia | Peptides neuroprotecteurs |
CN105315359A (zh) * | 2014-07-31 | 2016-02-10 | 北京泳健生物技术有限公司 | 一种缺失型重组人中脑星形胶质细胞源性神经营养因子 |
WO2016057579A1 (fr) * | 2014-10-06 | 2016-04-14 | Amarantus Bioscience Holdings, Inc. | Méthodes et compositions de traitement de troubles rétiniens |
EP3377089B1 (fr) | 2015-11-18 | 2020-04-08 | Herantis Pharma Plc | Compositions comprenant du cdnf pour le traitement par voie intranasale de maladies du système nerveux central |
CN107190102A (zh) * | 2016-05-09 | 2017-09-22 | 上海市同济医院 | 一种用于人源性manf基因检测的地高辛探针及其应用 |
EP3619227A1 (fr) | 2017-05-04 | 2020-03-11 | Helsingin Yliopisto | Fragments cdnf et manf c-terminaux, compositions pharmaceutiques les comprenant et leurs utilisations |
MX2020010301A (es) | 2018-03-29 | 2020-10-20 | Helsingin Yliopisto | Fragmentos de cdnf c-terminales, composiciones farmaceuticas que los comprenden y usos de los mismos. |
EP3838345A1 (fr) | 2019-12-20 | 2021-06-23 | Herantis Pharma Oyj | Peptides macrocycliques |
EP3838912A1 (fr) | 2019-12-20 | 2021-06-23 | Herantis Pharma Oyj | Peptides rétro inverses |
CN113292656B (zh) * | 2020-02-21 | 2022-10-25 | 四川大学华西医院 | 用于防治肥胖的中脑星形胶质细胞源性神经营养因子的融合蛋白 |
EP4223307A1 (fr) * | 2020-09-29 | 2023-08-09 | Cefo Co., Ltd. | Composition pour la prévention ou le traitement d'une maladie neuropsychologique, comprenant manf |
CN115887619B (zh) * | 2021-09-30 | 2024-03-26 | 四川大学 | 中脑星形胶质细胞源性神经营养因子的用途及药物组合物 |
GB202202898D0 (en) * | 2022-03-02 | 2022-04-13 | Babraham Inst | Novel use |
WO2023212658A2 (fr) * | 2022-04-27 | 2023-11-02 | Amarantus Bioscience Holdings | Compositions pour le traitement de complications liées à une maladie infectieuse et procédés associés |
WO2024030951A2 (fr) * | 2022-08-03 | 2024-02-08 | The Trustees Of Columbia University In The City Of New York | Facteur neurotrophique dérivé d'astrocytes mésencéphaliques (manf) pour prévenir et traiter des neuropathies périphériques |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
EP0088046B1 (fr) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipides en phase aqueuse |
EP0102324A3 (fr) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipides et composés tensio-actifs en phase aqueuse |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
EP0142641B1 (fr) | 1983-09-26 | 1991-01-16 | Udo Dr. Ehrenfeld | Moyen et produit pour le diagnostic et la thérapie de tumeurs ainsi que pour le traitement de déficiences du système immunitaire cellulaire et humoral |
EP0143949B1 (fr) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Composition pharmaceutique contenant de l'urokinase |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5106627A (en) | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
WO1991010470A1 (fr) | 1990-01-08 | 1991-07-25 | Brown University Research Foundation | Dispositifs et procedes d'apport ameliore de facteurs actifs |
US5670488A (en) | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
US5328688A (en) | 1990-09-10 | 1994-07-12 | Arch Development Corporation | Recombinant herpes simplex viruses vaccines and methods |
US5849571A (en) | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
US6071889A (en) | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
HU220795B1 (hu) | 1991-09-20 | 2002-05-28 | Amgen Inc. | Gliasejtvonal-eredetű neurotróf faktorfehérjék, továbbá berendezések és gyógyászati készítmények idegsejtkárosodás megelőzésére és kezelésére |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
US5879934A (en) | 1992-07-31 | 1999-03-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
US5661033A (en) | 1992-11-25 | 1997-08-26 | The Board Of Trustees Of The Leland Stanford Junior University | Gene transfer using herpes virus vectors as a tool for neuroprotection |
US5631237A (en) | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
WO1994017810A1 (fr) | 1993-02-12 | 1994-08-18 | The Wistar Institute Of Anatomy And Biology | Vaccin recombine contre le cytomegalovirus |
DE4311651A1 (de) | 1993-04-08 | 1994-10-13 | Boehringer Ingelheim Int | Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen |
CA2160583A1 (fr) | 1993-04-16 | 1994-10-27 | Stanley A. Plotkin | Vaccin de type cytomegalovirus recombinant |
AU7676894A (en) | 1993-08-27 | 1995-03-21 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Convection-enhanced drug delivery |
US5834441A (en) | 1993-09-13 | 1998-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral (AAV) liposomes and methods related thereto |
DK0733103T3 (da) | 1993-11-09 | 2004-07-12 | Univ Johns Hopkins | Fremstilling af höje titre af rekombinante AAV vektorer |
FR2716682B1 (fr) | 1994-01-28 | 1996-04-26 | Centre Nat Rech Scient | Procédé de préparation de virus adéno-associés (AAV) recombinants et utilisations. |
US5686278A (en) | 1994-03-25 | 1997-11-11 | Indiana University Foundation | Methods for enhanced retrovirus-mediated gene transfer |
US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
US5792453A (en) | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
US5707618A (en) | 1995-03-24 | 1998-01-13 | Genzyme Corporation | Adenovirus vectors for gene therapy |
FR2732357B1 (fr) | 1995-03-31 | 1997-04-30 | Rhone Poulenc Rorer Sa | Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose |
US5830725A (en) | 1995-04-28 | 1998-11-03 | The Board Of Trustees For The Leland Stanford Junior University | Rapid, stable high-titre production of recombing retrovirus |
US5773289A (en) | 1995-06-06 | 1998-06-30 | University Of Pittsburgh | AAV directed targeted integration |
US5622856A (en) | 1995-08-03 | 1997-04-22 | Avigen | High efficiency helper system for AAV vector production |
US6027931A (en) | 1995-08-03 | 2000-02-22 | Avigen, Inc. | High-efficiency AA V helper functions |
US5830727A (en) | 1995-11-18 | 1998-11-03 | Human Gene Therapy Research Institute | Herpes simplex virus amplicon mini-vector gene transfer system |
US5770414A (en) | 1996-02-20 | 1998-06-23 | The Regents Of The University Of California | Regulatable retrovirus system for genetic modification of cells |
PT1080202E (pt) | 1998-05-27 | 2006-05-31 | Avigen Inc | Distribuicao de vectores aav codificando aadc intensificada por conveccao |
AU7263300A (en) * | 1999-09-16 | 2001-04-17 | Neurotrophic Bioscience, Inc. | Opaminergic neuronal survival-promoting factors and uses thereof |
US20020132978A1 (en) | 2000-03-21 | 2002-09-19 | Hans-Peter Gerber | VEGF-modulated genes and methods employing them |
DK1373502T3 (da) | 2001-03-20 | 2011-01-10 | Amarantus Therapeutics Inc | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf |
CA2441327A1 (fr) | 2001-03-30 | 2002-10-10 | Geneprot, Inc. | Compositions proteiques humaines riches en arginine- |
WO2004087874A2 (fr) | 2003-03-28 | 2004-10-14 | Nuvelo, Inc. | Acides nucleiques et polypeptides |
ES2392430T3 (es) * | 2003-07-11 | 2012-12-10 | Develogen Aktiengesellschaft | Uso de productos de proteínas segregadas DG153 para prevenir y tratar enfermedades pancreáticas y/u obesidad y/o síndrome metabólico |
JP5236488B2 (ja) | 2005-12-14 | 2013-07-17 | ハーモ ファーマ エルテーデー. | 新規な神経栄養因子タンパク質およびその用途 |
TWI464634B (zh) * | 2009-10-09 | 2014-12-11 | Egalax Empia Technology Inc | 雙差動感測的方法與裝置 |
-
2008
- 2008-04-30 FI FI20080326A patent/FI20080326A0/fi not_active Application Discontinuation
-
2009
- 2009-04-30 CA CA2725128A patent/CA2725128C/fr active Active
- 2009-04-30 EP EP09738284.0A patent/EP2276778B1/fr active Active
- 2009-04-30 WO PCT/FI2009/050346 patent/WO2009133247A1/fr active Application Filing
- 2009-04-30 DK DK09738284.0T patent/DK2276778T3/en active
- 2009-04-30 ES ES09738284.0T patent/ES2530222T3/es active Active
- 2009-04-30 US US12/433,345 patent/US8853166B2/en active Active
-
2014
- 2014-09-09 US US14/480,975 patent/US9592270B2/en active Active
-
2015
- 2015-01-26 HR HRP20150095AT patent/HRP20150095T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20150095T1 (en) | 2015-03-13 |
US20150020222A1 (en) | 2015-01-15 |
EP2276778A1 (fr) | 2011-01-26 |
US9592270B2 (en) | 2017-03-14 |
CA2725128A1 (fr) | 2009-11-05 |
US8853166B2 (en) | 2014-10-07 |
US20090282495A1 (en) | 2009-11-12 |
DK2276778T3 (en) | 2015-02-09 |
EP2276778B1 (fr) | 2014-11-12 |
ES2530222T3 (es) | 2015-02-27 |
EP2276778A4 (fr) | 2011-07-06 |
WO2009133247A1 (fr) | 2009-11-05 |
CA2725128C (fr) | 2018-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20080326A0 (fi) | Neurotroofinen tekijä MANF ja sen käytöt | |
BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
BRPI0914134A2 (pt) | conjunto de componentes e estrutura de entrada de ar | |
DK2252395T3 (da) | Afsvovlingsmaterialer | |
FR2931125B1 (fr) | Deflecteur | |
BRPI0918328A2 (pt) | composição e artigo | |
FI20095084A0 (fi) | Komposiitti ja sen käyttö | |
BRPI0913807A2 (pt) | composição e artigo | |
DK2985033T6 (da) | Faktor VII-sammensætning | |
BRPI0918254A2 (pt) | bocal de reparo | |
AT8372U3 (de) | Desmopressin umfassende zusammensetzung | |
BRPI0911977A2 (pt) | quinazolinas substituídas | |
DK2382224T3 (da) | Metalhydracid-materialer | |
DK2277578T3 (da) | Forstøver | |
BRPI0918771A2 (pt) | composição de tinta | |
BRPI0911967A2 (pt) | quinazolinas substituídas | |
BRPI0920293A2 (pt) | nacela | |
BRPI0912672A2 (pt) | quinazolinas substituídas | |
DK2310037T3 (da) | Conglutin-gamma as-medikament og -kosttilskudpatentkrav | |
DE602008002817D1 (de) | Luftablenker | |
ES1068382Y (es) | Piqueta con autoanclaje | |
ES1069080Y (es) | Ferula anti-estereotipias manuales y anti-espasticidad manual | |
FI8149U1 (fi) | Ilmanesteaurinkokerääjä | |
FI7935U1 (fi) | Sisustuselementti | |
ES1068166Y (es) | Garita meteorologica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |